ZIVO Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:ZIVO Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
16 Oct 24	BuyUS$99,966	John Payne	Individual	6,343	US$15.76
16 Oct 24	BuyUS$49,993	Laith Yaldoo	Individual	3,133	US$15.96
22 Aug 24	BuyUS$261,342	Christopher Maggiore	Individual	31,336	US$8.34
22 Aug 24	BuyUS$99,997	Alison Cornell	Individual	11,990	US$8.34
26 Jul 24	BuyUS$16,744	Christopher Maggiore	Individual	2,080	US$8.05
12 Jun 24	BuyUS$29,999	Christopher Maggiore	Individual	3,764	US$7.97
02 Jan 24	BuyUS$49,999	Alison Cornell	Individual	41,666	US$1.20
29 Dec 23	BuyUS$205,000	Christopher Maggiore	Individual	157,692	US$1.30
13 Dec 23	BuyUS$45,000	Christopher Maggiore	Individual	45,000	US$1.00

Insider Buying: ZIVO insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 94.9%.

Top 9 shareholders own 62.27% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15%	Laith Yaldoo	533,424	US$10.0m	0.59%	no data
15%	HEP Investments, LLC	530,989	US$10.0m	0%	no data
14.1%	Christopher Maggiore	498,443	US$9.4m	7.19%	no data
7.27%	Alison Cornell	257,975	US$4.8m	4.87%	no data
5.6%	Mark Strome	198,644	US$3.7m	0%	no data
3.44%	Nola Masterson	122,024	US$2.3m	0%	no data
1.62%	Strome Investment Management, L.P.	57,506	US$1.1m	0%	11.42%
0.22%	John Payne	7,909	US$148.5k	405%	no data
0.039%	Andrew Dahl	1,387	US$26.0k	0%	no data